
Exciting news! Isagenix is pleased to announce that the University of
Illinois at Chicago (UIC) study that involved the Isagenix system is
receiving excellent recognition within the field of nutrition science.
The UIC study’s abstract won the American Society for Nutrition (ASN)
obesity research interest section abstract competition. In addition, the
study was selected for an oral presentation in April at ASN’s annual
meeting at the Experimental Biology conference in Boston.
Experimental Biology is one of the largest annual scientific
conferences to take place in the world. The event brings together
scientists and researchers from fields of anatomy, physiology,
biochemistry, pathology, nutrition, and pharmacology to discuss strides
and contributions in the field of science.
“It’s very impressive that we won, considering the
competition,” said Krista Varady, Ph.D., assistant professor at the
UIC College of Applied Health Sciences and the study’s principal
investigator. She explains that the abstract was chosen along with four
others as winners among more than 100 abstracts submitted within the
research interest section.
According to Isagenix Chief Science Officer Suk Cho, Ph.D., “It’s
exciting and an honor for these researchers to receive this type of
recognition. The study with Dr. Varady is novel with quality outcomes
that make winning this obesity research interest competition
well-deserved.”
The 10-week study demonstrated clear, clinical validation for the use
of an Isagenix system, which showed superior results when compared with
a “heart-healthy” dietary plan based on nationally recognized
guidelines. Notably, the Isagenix system led to a 56 percent greater
reduction in average weight loss, 47 percent greater reduction in
average body fat loss, twice as much visceral fat loss, and 35 percent
greater reduction of oxidative stress. The study subjects also reported
greater adherence on the Isagenix plan and that they considered it
convenient and easy to follow.
The study’s results were published in two peer-reviewed journals, Nutrition
and Metabolism and Nutrition
Journal. (Read more about the UIC study’s design and results
by reading our “Clinical
Research Summary” or viewing our “Isagenix
in Comparison to ‘Heart Healthy’ Diet” flyer.)
Nicholas Messina, M.D., former medical director and principal
investigator of numerous clinical trials, recently praised
the study for its randomized, double-arm design, as well as its
appropriate inclusion and exclusion criteria and clear objectives. He
wrote, “The bottom line is that this is a well-designed,
scientifically sound protocol that was carried out at a major university
research center by a skilled, published researcher. This was not the
common observational study that is often seen when evaluating
nutritional products.”